Healthy high growth potential

Results

254

4 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

254 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NVDA
US$195.74-7.1%26.3%US$4.8tUS$298.9329.721.8%0.5%Semiconductors
CRDO
US$268.03-1.4%182.0%US$50.2bUS$269.81105.827.5%n/aSemiconductors
CORT
US$84.756.1%14.0%US$8.8bUS$88.00194.948.9%n/aPharmaceuticals & Biotech
MDGL
US$513.791.6%71.5%US$11.8bUS$678.7110.559.2%n/aPharmaceuticals & Biotech
LITE
US$861.971.4%810.1%US$65.5bUS$1,111.29152.879.1%n/aTech
MOD
US$283.67-4.6%178.8%US$14.6bUS$340.86123.349.3%n/aCapital Goods
AXSM
US$237.33-5.3%131.4%US$12.2bUS$276.4717.257.4%n/aPharmaceuticals & Biotech
NU
US$12.46-2.0%-6.9%US$60.6bUS$17.864.820.2%n/aBanks
SMTC
US$162.272.6%255.7%US$14.8bUS$205.2513.974.6%n/aSemiconductors
ARM
US$347.71-20.9%119.9%US$383.5bUS$295.95410.835.6%n/aSemiconductors
AMD
US$532.57-0.9%270.7%US$847.5bUS$500.40176.135.1%n/aSemiconductors
BE
US$309.18-6.0%1,284.6%US$92.8bUS$266.9314577.244.9%n/aCapital Goods
SNDX
US$19.814.3%113.0%US$1.8bUS$39.008.168.2%n/aPharmaceuticals & Biotech
MRVL
US$281.26-9.4%251.7%US$242.1bUS$242.5097.425.7%0.09%Semiconductors
FN
US$567.79-1.0%89.9%US$20.4bUS$749.1148.323.3%n/aTech
MTSI
US$390.19-0.3%174.3%US$28.5bUS$403.00168.439.3%n/aSemiconductors
AVGO
US$378.91-7.9%40.2%US$1.8tUS$523.7361.533.5%0.7%Semiconductors
ALAB
US$398.00-4.6%306.3%US$68.5bUS$263.60254.929.4%n/aSemiconductors
RDDT
US$158.02-9.7%9.8%US$30.9bUS$224.9243.025.3%n/aMedia
LSCC
US$144.20-6.2%185.5%US$19.7bUS$146.92993.859.3%n/aSemiconductors
APP
US$445.93-5.1%28.3%US$156.2bUS$650.3038.322.0%n/aSoftware
ARDX
US$6.060.2%64.5%US$1.5bUS$16.303.555.9%n/aPharmaceuticals & Biotech
KRYS
US$359.933.4%152.4%US$10.2bUS$349.7847.236.6%n/aPharmaceuticals & Biotech
MRKR
US$1.31-1.5%-10.3%US$21.8mUS$7.876.269.0%n/aPharmaceuticals & Biotech
Page 1 of 8